Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,641 to 1,660 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Kasumi leukemia cell lines: characterization of tumor genomes with ethnic origin and scales of genomic alterations. | Hum Cell | 2020 | 32180206 | PubTator, text mining | PubMed |
| Chromatin accessibility promotes hematopoietic and leukemia stem cell activity. | Nat Commun | 2020 | 32179749 | PubTator, text mining | PubMed |
| Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia. | Br J Haematol | 2020 | 32175599 | PubTator, text mining | PubMed |
| Deep Transcriptome Sequencing of Pediatric Acute Myeloid Leukemia Patients at Diagnosis, Remission and Relapse: Experience in 3 Malaysian Children in a Single Center Study. | Front Genet | 2020 | 32174960 | PubTator, text mining | PubMed |
| Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study. | Lancet Oncol | 2020 | 32171069 | PubTator, text mining | PubMed |
| Role of the XIST-miR-181a-COL4A1 axis in the development and progression of keratoconus. | Mol Vis | 2020 | 32165822 | PubTator, text mining | PubMed |
How I curate: applying American Society of Hematology-Clinical Genome Resource Myeloid Malignancy Variant Curation Expert Panel rules for RUNX1 variant curation for germline predisposition to myeloid malignancies. | Haematologica | 2020 | 32165484 | PubTator, text mining | PubMed |
| Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data. | J Hematol Oncol | 2020 | 32164760 | PubTator, text mining | PubMed |
| Correction to: Role of HDACs in normal and malignant hematopoiesis. | Mol Cancer | 2020 | 32164749 | PubTator, text mining | PubMed |
| Nuclear myosin 1 activates p21 gene transcription in response to DNA damage through a chromatin-based mechanism. | Commun Biol | 2020 | 32161327 | PubTator, text mining | PubMed |
| Overcoming microenvironment-mediated protection from ATRA using CYP26-resistant retinoids. | Leukemia | 2020 | 32152463 | PubTator, text mining | PubMed |
| Deubiquitinases: Pro-oncogenic Activity and Therapeutic Targeting in Blood Malignancies. | Trends Immunol | 2020 | 32139316 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemia Presenting with Numb Chin Syndrome: A Case Report and Review of Literature. | Am J Case Rep | 2020 | 32123152 | PubTator, text mining | PubMed |
| Neoantigens in Hematologic Malignancies. | Front Immunol | 2020 | 32117272 | PubTator, text mining | PubMed |
| ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells. | Oncogene | 2020 | 32115572 | PubTator, text mining | PubMed |
| The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias. | Cells | 2020 | 32110991 | PubTator, text mining | PubMed |
| γ-Catenin Overexpression in AML Patients May Promote Tumor Cell Survival via Activation of the Wnt/β-Catenin Axis. | Onco Targets Ther | 2020 | 32103994 | PubTator, text mining | PubMed |
| High WBP5 expression correlates with elevation of HOX genes levels and is associated with inferior survival in patients with acute myeloid leukaemia. | Sci Rep | 2020 | 32103106 | PubTator, text mining | PubMed |
| Microfluidic Device for On-Chip Immunophenotyping and Cytogenetic Analysis of Rare Biological Cells. | Cells | 2020 | 32102446 | PubTator, text mining | PubMed |
| Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes. | Cancer | 2020 | 32101640 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=83